Savara SVRA Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Savara in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Savara's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Savara's accretion (amortization) of discounts and premiums, investments?
- Savara (SVRA) reported accretion (amortization) of discounts and premiums, investments of $565K in Q1 2026.
- How has Savara's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Savara's accretion (amortization) of discounts and premiums, investments decreased by 50.8% year-over-year, from $1.15M to $565K.
- What is the long-term trend for Savara's accretion (amortization) of discounts and premiums, investments?
- Over 3 years (2021 to 2025), Savara's accretion (amortization) of discounts and premiums, investments has grown at a 21.3% compound annual growth rate (CAGR), from -$1.6M to $2.87M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or the accretion of discounts on investment securities held by the company. It reflects the gradual adjustment of the carrying value of debt securities toward their par value over time. For a biopharmaceutical company, this highlights the yield management strategy on cash reserves held for R&D operations.